Cargando…

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey

SUMMARY: The effects of COVID-19 have the potential to impact on the management of chronic diseases including osteoporosis. A global survey has demonstrated that these impacts include an increase in telemedicine consultations, delays in DXA scanning, interruptions in the supply of medications and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuggle, N. R., Singer, A., Gill, C., Patel, A., Medeiros, A., Mlotek, A. S., Pierroz, D. D., Halbout, P., Harvey, N. C., Reginster, J.-Y., Cooper, C., Greenspan, S. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2021
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869913/ https://www.ncbi.nlm.nih.gov/pubmed/33558957 http://dx.doi.org/10.1007/s00198-020-05793-3

Ejemplares similares

Correction to: How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
por: Fuggle, N.R., et al.
Publicado: (2021)

COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey
por: Singer, A.J., et al.
Publicado: (2021)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases – the “Wco-iof-esceo Congress”: The 18th edition of the WCO-IOF-ESCEO Congress – Krakow 2018
por: Maślińska, Maria
Publicado: (2018)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021)
Publicado: (2022)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2022)
Publicado: (2022)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2022): Frontmatter
Publicado: (2022)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Poster Abstracts
Publicado: (2021)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Poster Abstracts
Publicado: (2022)

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
por: Hiligsmann, M., et al.
Publicado: (2019)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Meet-The-Experts Abstracts
Publicado: (2022)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Oral Communication Abstracts
Publicado: (2022)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Non-Sponsored Symposia Abstracts
Publicado: (2021)

World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Non-Sponsored Symposia Abstracts
Publicado: (2022)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Satellite Sponsored Symposium Abstracts
Publicado: (2022)

Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11): A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ESCEO) and the International Osteoporosis and Other Skeletal Diseases Foundation (IOF)
por: Rabenda, Véronique, et al.
Publicado: (2015)

A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network
por: Javaid, M. K., et al.
Publicado: (2020)

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
por: Hiligsmann, M., et al.
Publicado: (2018)

Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging
por: Shevroja, Enisa, et al.
Publicado: (2023)

IQ driving QI: the Asia Pacific Consortium on Osteoporosis (APCO): an innovative and collaborative initiative to improve osteoporosis care in the Asia Pacific
por: Chandran, M., et al.
Publicado: (2020)

Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
por: Chevalley, Thierry, et al.
Publicado: (2022)

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
por: Hadji, Peyman, et al.
Publicado: (2017)

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Moon, Rebecca J., et al.
Publicado: (2023)

IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference
Publicado: (2022)

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
por: Kanis, J. A., et al.
Publicado: (2017)

Re: Errors in the NOF meta-analysis of calcium and vitamin D supplements
por: Weaver, C. M., et al.
Publicado: (2016)

Construction of a predictive model for osteoporosis risk in men: using the IOF 1-min osteoporosis test
por: Zhang, Kun, et al.
Publicado: (2023)

IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference : Poster Abstracts
Publicado: (2022)

Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Diez-Perez, Adolfo, et al.
Publicado: (2019)

Osteoporosis in the age of COVID-19
por: Girgis, C. M., et al.
Publicado: (2020)

Validation of the IOF quality of life questionnaire for patients with wrist fracture
por: Lips, P., et al.
Publicado: (2009)

IRON NOF trial: IV iron for anaemic patients with femoral fracture
por: O'Loughlin, Edmond, et al.
Publicado: (2023)

Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Bruyère, Olivier, et al.
Publicado: (2017)

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
por: Pavelka, Karel, et al.
Publicado: (2016)

Early Osteoporosis Risks and Associated Factors among Caregivers Working in Disability Institutions: IOF One-Minute Osteoporosis Risk Check
por: Lin, Lan-Ping, et al.
Publicado: (2020)

NOF1 Encodes an Arabidopsis Protein Involved in the Control of rRNA Expression
por: Harscoët, Erwana, et al.
Publicado: (2010)

Osteoporosis in the European Union: medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)
por: Hernlund, E., et al.
Publicado: (2013)

Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?
por: Quinn, Lauren A., et al.
Publicado: (2021)

Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs
por: Fuggle, N. R., et al.
Publicado: (2020)

Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation?
por: Paskins, Z., et al.
Publicado: (2020)

Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO)
por: Al-Daghri, Nasser M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q24pjvbnha3gtaio9g7ij7s84h